Detection of IL-35 in plasma in the patients with active tuberculosis complicated with bronchiectasis and its clinical significance / 国际检验医学杂志

Objective To detect plasma interleukins-35 (IL-35 )level in the patients with active tuberculosis complicated with bronchiectasis and to analyze its clinical significance.Methods Peripheral blood of patients with active tuberculosis from depart-ment of Dongguan 6th People′s hospital were collected,assigned to the active tuberculosis complicated with bronchiectasis group and active tuberculosis group.The healthy volunteers served as the control group.The plasma IL-35 level was measured by ELISA, and peripheral blood neutrophils and lymphocytes were detected by hematology analyzer.Results The levels of plasma IL-35 signif-icantly increased in both patients with active tuberculosis complicated with bronchiectasis and patients with active tuberculosis.The level of plasma IL-35 of patients with active tuberculosis complicated with bronchiectasis was significantly higher than that of the patients with active tuberculosis.The absolute value and percentage of peripheral blood neutrophils of patients with active tubercu-losis complicated with bronchiectasis were significantly higher than those of healthy volunteers.However,the percentage of periph-eral blood lymphocytes of patients with active tuberculosis complicated with bronchiectasis was significantly lower than that of healthy volunteers.Pearson correlation analysis showed that the absolute value of peripheral blood neutrophils of patients with ac-tive tuberculosis was positively correlated to the level of plasma IL-35.Conclusion IL-35 may play an important role in the progres-sion of active tuberculosis complicated with bronchiectasis.The determination of IL-35 may be helpful to the diagnosis of patients with active tuberculosis complicated with bronchiectasis.

Comparative Analysis of Clinical Efficacy and X-ray Evolution of New Smear Positive Pulmonary Tuberculosis:A Report of 3229 Cases / 实用放射学杂志

Objective To evaluate the shore-term efficacy and the X-ray evolution of new smear positive pulmonary tuberculosis after short-course chemotherapy. Methods 3229 cases with new smear positive pulmonary tuberculosis were treated with 2H_3R_3Z_3S_3/4H_3R_3 or 2 H_3R_3Z_3E_3/4H_3R_3 chemotherapy.Clinical efficacy and the X-ray evolution were analyzed after treatment. Results Among 3229 cases after treatment,the clinical cure rate and chest X-ray effective rate were 98%(3163/3229) and 98%(3163/3229) respectively. Conclusion The standardized chemotherapy treatment can achieve high clinical cure rate and X-ray cure rate for pulmonary tuberculosis.